genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
News
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet…
News
Autistic Symptoms Can Be Suppressed by Inhibiting Specific Enzyme
News
Parkinson’s Disease Odor Characterized with the Help of Human “Super Smeller”
News
Epigenetic Marks on Sperm Chromosomes Impact Gene Expression in Offspring
Insights
Commentary
Limitations in Single-Cell Analysis Must Be Addressed with Innovation
Cannabinoids
Liquid Gold: Engineers Strike Oil Making Customized Extractors for Cannabis
Bioprocessing
Addressing Challenges Posed by the Adoption of Single-Use Systems
Insights
Top 15 Best-Selling Drugs of 2018
Insights
Phage Therapy: Turning the Tables on Bacteria
A-Lists
Insights
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
March 2019 Vol. 39 No. 3
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
News
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet…
News
Parkinson’s Disease Odor Characterized with the Help of Human “Super Smeller”
News
Epigenetic Marks on Sperm Chromosomes Impact Gene Expression in Offspring
Magazine
All
Supplement
Insights
Phage Therapy: Turning the Tables on Bacteria
March 2019 Vol. 39 No. 3
Keeping Up with Bioprocess Changes
March 2019 Vol. 39 No. 3
Circulating Tumor Cells and the Liquid Biopsy
Insights
Novel Oncology Drug Discovery Strategies
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
Multiplexed Target Enrichment and High-Resolution NGS Analysis of On- and…
Webinars
Fibro-Inflammatory Disease Sees Relief in IL-11 mAb Development
eBooks
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
GENcast
GENcast: Explore, Learn, and Collaborate on Cell & Gene Therapy Manufacturing…
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Therapeutics
Respiratory Drugs
Respiratory Drugs
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Respiratory Drugs
Influenza Drug Platform Could Yield Candidates for Multiple Pathogens
Respiratory Drugs
Fish Oil for Asthma? Don’t Hold Your Breath
Respiratory Drugs
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Respiratory Drugs
Vectura Scraps Asthma Drug-Device VR475 after Phase III Failure
Respiratory Drugs
Oily Fish Reduces Airway Inflammation in Asthmatic Children
Respiratory Drugs
AbbVie Takes Control of Cystic Fibrosis Collaboration with Galapagos
Respiratory Drugs
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans...
Respiratory Drugs
Cell Network Study Shines Light on Lung Cancer Signal Pathways
Respiratory Drugs
IL-26 Offers New Therapeutic Target for Chronic Smokers with Lung Disease
Respiratory Drugs
Common Cold Blocked from Replicating by Novel Drug Molecule
Respiratory Drugs
AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
Respiratory Drugs
Telomerase Gene Therapy Cures Pulmonary Fibrosis in Mice
Respiratory Drugs
Regeneron Genetics Center Surpasses 250K Exomes Sequenced, and Ramping Up
Respiratory Drugs
AstraZeneca Asthma Candidate Tralokinumab Fails Two Phase III Trials
Respiratory Drugs
Gates Foundation Invests up to $40M in Immunocore to Develop TCR-Based...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Interleukin-26 (IL-26) is increased among chronic smokers with lung disease. [DjelicS/Getty Images]](https://www.genengnews.com/wp-content/uploads/2018/08/May21_2018_Getty_884674820_WomanSmokingCoughing_6004045781456-324x160.jpg "IL-26 Offers New Therapeutic Target for Chronic Smokers with Lung Disease")
